InvestorsHub Logo
Followers 53
Posts 3618
Boards Moderated 0
Alias Born 06/07/2011

Re: None

Saturday, 08/16/2014 6:30:04 AM

Saturday, August 16, 2014 6:30:04 AM

Post# of 12450
I find it amazing how many people believe that HC Wainwright began coverage on Pacific Therapeutics! In reality, it is Pacific Therapeutics saying HC Wainwright has initiated coverage on Intelgenx, which is old news! The headline reads like this:

H.C. Wainwright Initiates Coverage of Pacific Therapeutics Partner Intelgenx with a Buy Recommendation

http://www.news10.com/story/26289320/hc-wainwright-initiates-coverage-of-pacific-therapeutics-partner-intelgenx-with-a-buy-recommendation

They are not reading the headline correctly... IMO, and only my opinion, I believe Pacific Therapeutics is trying to drum up some trading in their stock now that they are on the OTC pink sheets under the symbol PCFTF. They were only listed on the Canadian exchange before. They started trading on the OTC on May 12, 2014 and since then there have only been 5 days with volume, and low volume at that! The last day a trade was made in it was July 25, 2014.

Also, remember, if you decide to trade PCFTF, it is a foreign issue stock, hence the F at the end of the symbol. You will pay a fee of roughly $20.00 for a round trip trade. $10.00 at buy in and $10.00 at exit. This is above and beyond your trading commissions!


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IGXT News